Oncosoft Inc.

Oncosoft is an AI-driven software company specializing in radiation oncology workflows. The company develops an end-to-end intelligent ecosystem that supports every step of radiotherapy planning, from patient imaging through treatment planning and chart close-out. Its flagship product, OncoStudio, uses clinical-grade AI for automatic organ segmentation (auto-contouring) and organ-at-risk delineation, reducing manual contouring time from hours to minutes. OncoFlow provides integrated workflow management to eliminate errors across the entire radiotherapy process. Products under development include OncoPlan for particle therapy optimization and OncoRPT for radiopharmaceutical therapy personalization. Oncosoft supports DICOM and HL7 FHIR standards, works with 190+ normal organs and clinical target volumes, and is expanding to 300+ structures by 2025. The platform currently operates on local institutional servers with cloud deployment planned for 2026. Backed by partnerships with major Korean hospitals and expanding into U.S. and Japanese markets.